246 related articles for article (PubMed ID: 19674764)
1. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
Sui Q; Huang J; Deng S; Yu G; Fan Q
Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
3. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
4. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites.
Weigel S; Berger U; Jensen E; Kallenborn R; Thoresen H; Hühnerfuss H
Chemosphere; 2004 Aug; 56(6):583-92. PubMed ID: 15212901
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea.
Behera SK; Kim HW; Oh JE; Park HS
Sci Total Environ; 2011 Sep; 409(20):4351-60. PubMed ID: 21807398
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
[TBL] [Abstract][Full Text] [Related]
7. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan.
Lin AY; Yu TH; Lateef SK
J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and removal of endocrine-disrupting chemicals in wastewater treatment plants in the Three Gorges Reservoir area, Chongqing, China.
Ye X; Guo X; Cui X; Zhang X; Zhang H; Wang MK; Qiu L; Chen S
J Environ Monit; 2012 Aug; 14(8):2204-11. PubMed ID: 22695474
[TBL] [Abstract][Full Text] [Related]
10. Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Busetti F; Linge KL; Heitz A
J Chromatogr A; 2009 Jul; 1216(31):5807-18. PubMed ID: 19560149
[TBL] [Abstract][Full Text] [Related]
11. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan.
Lin AY; Lin CF; Tsai YT; Lin HH; Chen J; Wang XH; Yu TH
Water Sci Technol; 2010; 62(10):2450-8. PubMed ID: 21076233
[TBL] [Abstract][Full Text] [Related]
12. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
[TBL] [Abstract][Full Text] [Related]
13. Solid-phase extraction followed by liquid chromatography-time-of-flight-mass spectrometry to evaluate pharmaceuticals in effluents. A pilot monitoring study.
Gómez MJ; Malato O; Ferrer I; Agüera A; Fernández-Alba AR
J Environ Monit; 2007 Jul; 9(7):718-29. PubMed ID: 17607393
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece.
Kosma CI; Lambropoulou DA; Albanis TA
J Hazard Mater; 2010 Jul; 179(1-3):804-17. PubMed ID: 20395039
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants.
Falås P; Andersen HR; Ledin A; la Cour Jansen J
Water Sci Technol; 2012; 66(4):783-91. PubMed ID: 22766867
[TBL] [Abstract][Full Text] [Related]
17. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan.
Okuda T; Kobayashi Y; Nagao R; Yamashita N; Tanaka H; Tanaka S; Fujii S; Konishi C; Houwa I
Water Sci Technol; 2008; 57(1):65-71. PubMed ID: 18192742
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of androgens and progestogens in wastewater treatment plants and receiving river waters: comparison to estrogens.
Chang H; Wan Y; Wu S; Fan Z; Hu J
Water Res; 2011 Jan; 45(2):732-40. PubMed ID: 20850861
[TBL] [Abstract][Full Text] [Related]
19. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants.
Okuda T; Yamashita N; Tanaka H; Matsukawa H; Tanabe K
Environ Int; 2009 Jul; 35(5):815-20. PubMed ID: 19201472
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS.
Batt AL; Kostich MS; Lazorchak JM
Anal Chem; 2008 Jul; 80(13):5021-30. PubMed ID: 18498179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
